News
Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...
2mon
GlobalData on MSNMerck and Opentrons to automate assay kits on custom workstationMerck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex ...
The Bayesian Back End software (in short BayBE) represents the development of an AI-assisted experimental planner by Merck scientists across the entire group. The project has grown into an ...
German industrial giant Siemens AG said today it will pay $5.1 billion to acquire the life sciences data startup Dotmatics in an effort to expand its artificial intelligence offerings.
March 25 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals (600276.SS), opens new tab worth up to $2 billion ...
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data sho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results